Authors

Latest Article

Recap: Day 3 of Asembia AXS26

These discussions focused on gaps in artificial intelligence, community-based advanced therapy, and demands of federal drug price negotiations.

Trending on Drug Topics

FDA Approves New Drug for HSV Lesions in Adults

American Pharmacists Month: Celebrating the Pharmacist’s Community Role

Q&A: Emerging Compounded Therapies Demand Pharmacist’s Clinical Judgment | NCPA 2026

OTC: Back-to-School Health

Pharmacists Improve Access, Safe Use of Obesity Medications